Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Over the past 40 years, it has become apparent that melioidosis is not only highly endemic in Southeast Asia and northern Australia but is also widespread elsewhere in the tropics. Modelling suggests that there could be as many as 165,000 cases in 79 countries around the world each year, leading to some 89,000 deaths, with some 44% of these occurring in South Asia. In reality, far fewer cases than this are being diagnosed. There are numerous obstacles to accurate surveillance, especially since this is an infection that predominantly affects the rural poor, who are the last people to have access to good diagnostics. The potential for Burkholderia pseudomallei to be used as a bioweapon has had beneficial spin-offs, no matter how unlikely it is ever to be used in this way. Nonetheless, melioidosis deserves to be formally recognized as a neglected tropical disease (NTD) in the hope that this will help to raise awareness, improve management, and reduce the avoidable death toll from this silent killer.

More information Original publication

DOI

10.1201/9781003324010

Type

Chapter

Publisher

CRC Press

Publication Date

2023-05-15T00:00:00+00:00